Pharmaceutical Market Europe • October 2024 • 37
APPOINTMENTS
UCB
Nico Reynders
UCB has appointed Nico Reynders as general manager of its UK and Ireland affiliate. Reynders has significant industry experience and has held a wide range of roles over 14 years at UCB, including periods in the US and China. He takes on his latest position after heading up the company’s global bone health business in Belgium. Prior to this, he served as senior vice-president of HR and head of HR for immunology and neurology, following his role as head of global HR business partnering. Before joining UCB as vice-president HR Asia-Pacific, he enjoyed an extensive career, including consulting for Accenture, where he was responsible for several large-scale change management and organisational design programmes. In his latest role, Reynders will lead UCB’s UK and Ireland affiliate to deliver on the company’s ambitions in immunology, neurology and rare diseases.
iTeos Therapeutics
David Feltquate
iTeos Therapeutics has appointed David Feltquate as chief medical officer. Feltquate brings almost 20 years of experience to his latest role. He most recently served as chief medical officer at Palleon Pharmaceuticals and was previously global head of haematology development and chair of the precision medicine leadership team at Novartis.
Rectify Pharmaceuticals
Pol Boudes
Rectify Pharmaceuticals has appointed Pol Boudes as chief medical officer. Boudes has over 30 years of experience and joins the company from Galectin Therapeutics, where he has been serving as chief medical officer. Boudes held the same position at CymaBay Therapeutics and Amicus Therapeutics, and previously worked in senior international roles at Bayer and Roche.
Skye Bioscience
Puneet Arora
Skye Bioscience has appointed Puneet Arora as chief medical officer. Arora, a board-certified physician in endocrinology, diabetes and metabolism, joins Skye from Lassen Therapeutics, where he served as chief medical officer. Prior to this, he was head of clinical development at Principia Biopharma, a Sanofi company, and held roles at Genentech and Amgen.
Structure Therapeutics
Blai Coll
Structure Therapeutics has appointed Blai Coll as chief medical officer. Coll is a physician-scientist with 15 years of experience in clinical development and most recently served as vice president of endocrine and metabolism clinical development at Structure. He previously held a number of leadership positions in Amgen’s cardiovascular group and was medical director at AbbVie.
Biocartis
W Michael Korn
Biocartis has appointed W Michael Korn as chief medical and scientific officer. Korn brings extensive experience to the role and most recently served as chief medical officer at Invitae, after holding the same position at Caris Life Sciences. He is also a faculty member at the University of California San Francisco in the division of haematology/oncology.
Boston Scientific
Angelo Auricchio
Boston Scientific has appointed Angelo Auricchio as chief medical officer of Rhythm Management in EMEA. Auricchio was recently deputy head of the cardiology division and director of the clinical electrophysiology unit at Istituto Cardiocentro Ticino. He holds professorships at Università della Svizzera italiana and University Hospital Magdeburg.
Kelso Pharma
John Rooper
Kelso Pharma has appointed John Rooper as director of corporate development. Rooper has a wealth of experience in the life sciences sector and joins Kelso from Advanz Pharma, where he served as associate director of mergers and acquisitions (M&A). Prior to this, Rooper held a senior M&A role at Ernst and Young.
Latigo Biotherapeutics
Neil Singla
Latigo Biotherapeutics has appointed Neil Singla as chief medical officer. Singla has significant experience in analgesic protocol design and implementation, and is the founder and previous chief executive officer of Lotus Clinical Research. He also currently chairs the Clinical Trials Special Interest Group for the International Association for the Study of Pain.
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services